Aim the science at cures
Research incentives point at cures, vaccines, and prevention — not lifetime-subscription therapeutics. A system that profits from maintaining disease will manufacture maintenance; redirect the profit and it will manufacture cures.
Prevention first, escalation second
Diet, movement, and preventative, holistic care are the first prescription. When diagnosis shows advanced disease, the full weight of conventional medicine arrives without delay. Both traditions, in the right order — not one instead of the other.
Ten years for the inventor, then everyone
The discoverer of a cure is paid like a hero — a decade of exclusive benefit, prize purses, and the credit of a Nobel. On year eleven the formula opens to all, generic from that day forward. Inventors keep competing because the next cure pays like the last one; the sick stop paying forever for the first.
Universal coverage, private freedom
Medical insurance is universal — every citizen carries it from birth. The wealthy may keep and fund private systems alongside it, and employers may subsidize premium access as the retention incentive it already is. The floor is guaranteed; the ceiling is yours to buy.
The Senator waits in the same line
Every public official — President, Congress, judges — and their families use the public system for their care, regardless of wealth. No privilege the lowest earner lacks. When the people who set the floor have to stand on it, the floor stays high — and if it is terrible, it gets fixed with remarkable speed.
Free will, owned outcomes
Every citizen may refuse medical advice — that freedom is not negotiable. But where disease is built by choices — the diet kept, the regimen refused, the warnings waved off — the added cost of that refusal is a personal debt, not a public one. This is not about the illness that finds you; it is about the illness you feed. Liberty and the bill arrive together.